PL2101777T3 - Kompozycja do leczenia nadciśnienia płucnego - Google Patents

Kompozycja do leczenia nadciśnienia płucnego

Info

Publication number
PL2101777T3
PL2101777T3 PL07855065T PL07855065T PL2101777T3 PL 2101777 T3 PL2101777 T3 PL 2101777T3 PL 07855065 T PL07855065 T PL 07855065T PL 07855065 T PL07855065 T PL 07855065T PL 2101777 T3 PL2101777 T3 PL 2101777T3
Authority
PL
Poland
Prior art keywords
treating
composition
pulmonary hypertension
hypertension
pulmonary
Prior art date
Application number
PL07855065T
Other languages
English (en)
Polish (pl)
Inventor
Michael J Gerber
Christopher Dufton
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39092031&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2101777(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of PL2101777T3 publication Critical patent/PL2101777T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07855065T 2006-12-12 2007-12-11 Kompozycja do leczenia nadciśnienia płucnego PL2101777T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86966706P 2006-12-12 2006-12-12
EP07855065.4A EP2101777B1 (en) 2006-12-12 2007-12-11 Composition for treating a pulmonary hypertension
PCT/US2007/087058 WO2008073928A1 (en) 2006-12-12 2007-12-11 Composition for treating a pulmonary hypertension

Publications (1)

Publication Number Publication Date
PL2101777T3 true PL2101777T3 (pl) 2015-10-30

Family

ID=39092031

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07855065T PL2101777T3 (pl) 2006-12-12 2007-12-11 Kompozycja do leczenia nadciśnienia płucnego

Country Status (15)

Country Link
US (7) US20080139593A1 (enExample)
EP (2) EP2952193A1 (enExample)
JP (1) JP2010512414A (enExample)
AU (1) AU2007333115B2 (enExample)
CA (1) CA2669536C (enExample)
CY (1) CY2016017I2 (enExample)
DK (1) DK2101777T3 (enExample)
ES (1) ES2544724T3 (enExample)
HK (1) HK1218393A1 (enExample)
HU (2) HUE025355T2 (enExample)
LU (1) LU93081I2 (enExample)
PL (1) PL2101777T3 (enExample)
PT (1) PT2101777E (enExample)
SI (1) SI2101777T1 (enExample)
WO (1) WO2008073928A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2101777T3 (pl) 2006-12-12 2015-10-30 Gilead Sciences Inc Kompozycja do leczenia nadciśnienia płucnego
EP2170397A1 (en) 2007-07-11 2010-04-07 Lexicon Pharmaceuticals, Inc. Methods and compositions for treating pulmonary hypertension and related diseases and disorders
JP2010535210A (ja) 2007-07-31 2010-11-18 ギリード・コロラド・インコーポレーテッド アンブリセンタンの代謝産物および誘導体
WO2010062640A1 (en) * 2008-10-28 2010-06-03 Gilead Colorado, Inc. Methods for treating idiopathic pulmonary fibrosis and associated complications
JP2013533882A (ja) * 2010-06-30 2013-08-29 ギリアード サイエンシーズ， インコーポレイテッド 肺高血圧症を処置するためのａ２ｂアデノシン受容体アンタゴニストの使用
EP3106163A1 (en) 2010-10-15 2016-12-21 Gilead Sciences, Inc. Compositions and methods of treating pulmonary hypertension
US20140271680A1 (en) * 2011-08-12 2014-09-18 Universite Paris-Est Creteil Val De Marne Methods and pharmaceutical compositions for treatment of pulmonary hypertension
WO2013130119A1 (en) * 2012-02-29 2013-09-06 Gilead Sciences, Inc. Method for treating a pulmonary hypertension condition without companion diagnosis
US20130225595A1 (en) * 2012-02-29 2013-08-29 Gilead Sciences, Inc. Method for treating pulmonary arterial hypertension in a patient not having idiopathic pulmonary fibrosis
WO2014003678A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
US10518112B2 (en) 2014-06-18 2019-12-31 Sonivie Ltd. Method for treating secondary pulmonary hypertension
US10576083B2 (en) * 2015-08-13 2020-03-03 Cipla (UK) Limited Method of treating pulmonary arterial hypertension
RS62011B1 (sr) 2016-07-15 2021-07-30 Acceleron Pharma Inc Kompozicije koje sadrže polipeptide actriia za upotrebu u lečenju plućne hipertenzije
JP2020532531A (ja) * 2017-08-30 2020-11-12 ベレロフォン パルス テクノロジーズ エルエルシー 肺疾患に関連付けられる肺高血圧症の治療のための吸入用一酸化窒素の使用
TW201929841A (zh) * 2017-12-28 2019-08-01 美商柏勒洛豐脈衝科技有限責任公司 吸入一氧化氮和氧氣用於治療肺高血壓的用途
JP2022532076A (ja) * 2019-05-06 2022-07-13 アクテリオン ファーマシューティカルズ リミテッド サルコイドーシス関連肺高血圧症の治療方法
CA3161960A1 (en) 2019-12-16 2021-06-24 Tenax Therapeutics, Inc. Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (ph-hfpef)
RU2729033C1 (ru) * 2020-02-03 2020-08-03 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр кардиологии" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ кардиологии" Минздрава России) Способ прогнозирования эффективности длительной специфической терапии у пациентов с идиопатической легочной гипертензией и неоперабельной хронической тромбоэмболической легочной гипертензией
EP4142731A1 (en) * 2020-04-28 2023-03-08 Noorik Biopharmaceuticals AG Treatment of pulmonary complications of coronavirus infections
EP3906928A1 (en) * 2020-05-06 2021-11-10 Noorik Biopharmaceuticals AG Treatment of pulmonary complications of coronavirus
CN114324900A (zh) * 2021-12-03 2022-04-12 上海市肺科医院 一种促卵泡激素的应用
EP4456897A4 (en) 2021-12-31 2025-12-10 Tenax Therapeutics Inc ORAL FORMULATIONS OF LEVOSIMENDAN FOR THE TREATMENT OF PULMONARY HYPERTENSION WITH HEART FAILURE AND PRESERVED EJECTION FRACTION
JP2026500956A (ja) * 2023-01-09 2026-01-09 エスシーファーマシューティカルズ インコーポレイテッド ループ利尿薬を使用した治療の方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US4325525A (en) 1980-11-13 1982-04-20 General Motors Corporation Mounting member
US5364620A (en) 1983-12-22 1994-11-15 Elan Corporation, Plc Controlled absorption diltiazem formulation for once daily administration
US4902514A (en) 1988-07-21 1990-02-20 Alza Corporation Dosage form for administering nilvadipine for treating cardiovascular symptoms
US5250534A (en) 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
DE4313412A1 (de) 1993-04-23 1994-10-27 Basf Ag 3-(Het)aryl-Carbonsäurederivate, Verfahren und Zwischenprodukte zu ihrer Herstellung
GB9401090D0 (en) 1994-01-21 1994-03-16 Glaxo Lab Sa Chemical compounds
DE19533023B4 (de) 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
SK287161B6 (sk) 1997-11-12 2010-02-08 Bayer Healthcare Ag 2-Fenylsubstituované imidazotriazinóny, spôsob ich výroby, liečivá obsahujúce tieto látky a ich použitie
US6821975B1 (en) 1999-08-03 2004-11-23 Lilly Icos Llc Beta-carboline drug products
WO2006007213A1 (en) * 2004-06-23 2006-01-19 Myogen, Inc. Enoximone formulations and their use in the treatment of pde-iii mediated diseases
TW200621261A (en) 2004-08-26 2006-07-01 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
US20060205733A1 (en) * 2004-08-26 2006-09-14 Encysive Pharmaceuticals Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof
US7511035B2 (en) 2005-01-25 2009-03-31 Glaxo Group Limited Antibacterial agents
ES2366239T3 (es) * 2006-04-21 2011-10-18 Pfizer Products Inc. Piridin[3,4-b]pirazinonas.
PL2101777T3 (pl) 2006-12-12 2015-10-30 Gilead Sciences Inc Kompozycja do leczenia nadciśnienia płucnego
US20080139483A1 (en) * 2006-12-12 2008-06-12 Gorczynski Richard J Drug combination for hypertensive disorders
JP2010535210A (ja) 2007-07-31 2010-11-18 ギリード・コロラド・インコーポレーテッド アンブリセンタンの代謝産物および誘導体
WO2010062640A1 (en) 2008-10-28 2010-06-03 Gilead Colorado, Inc. Methods for treating idiopathic pulmonary fibrosis and associated complications
EP3106163A1 (en) 2010-10-15 2016-12-21 Gilead Sciences, Inc. Compositions and methods of treating pulmonary hypertension

Also Published As

Publication number Publication date
US9474752B2 (en) 2016-10-25
HK1218393A1 (en) 2017-02-17
US9993475B2 (en) 2018-06-12
US20130116257A1 (en) 2013-05-09
LU93081I2 (fr) 2016-07-20
US20150224100A1 (en) 2015-08-13
EP2101777A1 (en) 2009-09-23
CY2016017I1 (el) 2016-10-05
US8377933B2 (en) 2013-02-19
US20080139593A1 (en) 2008-06-12
ES2544724T3 (es) 2015-09-03
HUE025355T2 (en) 2016-02-29
EP2101777B1 (en) 2015-05-20
JP2010512414A (ja) 2010-04-22
US20170136016A1 (en) 2017-05-18
CA2669536A1 (en) 2008-06-19
EP2952193A1 (en) 2015-12-09
AU2007333115B2 (en) 2013-01-10
SI2101777T1 (sl) 2015-08-31
US20100152217A1 (en) 2010-06-17
DK2101777T3 (en) 2015-08-17
US20140296244A1 (en) 2014-10-02
CA2669536C (en) 2016-05-31
HUS1600027I1 (hu) 2016-06-28
AU2007333115A1 (en) 2008-06-19
CY2016017I2 (el) 2016-10-05
US9504685B2 (en) 2016-11-29
US20110245253A1 (en) 2011-10-06
PT2101777E (pt) 2015-09-18
WO2008073928A1 (en) 2008-06-19

Similar Documents

Publication Publication Date Title
HUS1600027I1 (hu) Kompozíció pulmonáris hipertensio kezeléséhez
PT2094708E (pt) Pirrolopirazina como inibidor da cinase syk
EP2065444A4 (en) PHOTOPOLYMERIZABLE COMPOSITION
GB0612845D0 (en) Deacidification method
GB0625586D0 (en) Composition
GB0607605D0 (en) Composition
GB0701048D0 (en) A composition
GB0621554D0 (en) Batten
EP2059135A4 (en) NOVEL COMPOSITION
GB0623619D0 (en) Composition
GB0820885D0 (en) A composition for the treatment of hypertension
GB0625430D0 (en) Composition
GB0625429D0 (en) Composition
GB0611408D0 (en) Ballast
GB0625841D0 (en) Composition
GB0623618D0 (en) Composition
GB0500922D0 (en) A therapy for pulmonary hypertension
HK1140689A (en) Methods and compositions for treating pulmonary hypertension
HU0600193V0 (en) Latch-cover for water-network
GB0622883D0 (en) Composition
GB0602185D0 (en) Composition
GB0624697D0 (en) Composition
GB0621345D0 (en) Composition
GB0620435D0 (en) Composition
GB0620338D0 (en) Composition